Results 121 to 130 of about 39,275 (210)

Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. [PDF]

Children (Basel)
Zaitoon H, Wauters AD, Rodriguez LM, Lynch JL.   +3 more
europepmc   +1 more source

Orforglipron: A Comprehensive Review of an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity and Type 2 Diabetes. [PDF]

Int J Mol Sci
Kansakar U, Jankauskas SS, Pande S, Mone P, Varzideh F, Santulli G.   +5 more
europepmc   +1 more source

Gestational Weight Gain and Pregnancy Outcomes After GLP-1 Receptor Agonist Discontinuation. [PDF]

JAMA
Maya J, Pant D, Fu Y, James K, Batlle C, Hsu S, Soria-Contreras DC, Shook LL, Mow C, Hivert MF, Thaweethai T, Powe CE.   +11 more
europepmc   +1 more source

Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis. [PDF]

Orphanet J Rare Dis
Nguefang GL, Boateng S, Gyabaah S, Issaka Y, Konlack JG, Landa EL, Eze E, Njei B.   +7 more
europepmc   +1 more source

GLP-1 Receptor Agonist-Associated Weight Loss and Aesthetic Breast Surgery: A Narrative Review and Experience-Based Recommendations for Plastic and Reconstructive Surgeons. [PDF]

Aesthet Surg J Open Forum
Nahabedian MY, Deva AK, Ahmed D, Fanzio P, Hammer J.   +4 more
europepmc   +1 more source

Perioperative GLP-1 Receptor Agonist Use is Associated With Reduced Revisions and Complications Following ACDF: A Propensity-Matched Analysis. [PDF]

Global Spine J
Kim MT, Lee S, Goh GS, Riew KD.
europepmc   +1 more source

GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases.

JAMA Netw Open
Chi KY, Chang Y, Song J, Chen CM, Perng PS, Lin HM.   +5 more
europepmc   +1 more source

Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Tzang CC, Wu PH, Luo CA, Chen ZT, Lee YT, Huang ES, Kang YF, Lin WC, Tzang BS, Hsu TC.   +9 more
europepmc   +1 more source

Efficacy and safety of orforglipron, an oral small-molecule GLP-1 receptor agonist, on cardiometabolic outcomes: a meta-analysis and systematic review. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Alper A, Peleg G, Fagin A, Shah P, Chowdhury I, Gonzales A, Faillace R.   +6 more
europepmc   +1 more source

The Cautious Promise of GLP-1 Receptor Agonists

Ochsner Journal
openaire   +2 more sources